Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

DMH-1

Inquiry
Cat. No.: OB0125LY-069
Size: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 500 mg
CAS No.: 1206711-16-1
Compound CID: 50997747
DMH-1

Specification

Description: DMH-1 is a small molecule compound that blocks BMP signaling by inhibiting the phosphorylation activity of Smad1 and Smad5.
Formula Weight: 380.44
Stability: 3 years in powder form.
Applications: DMH-1 can be used to explore the role of BMP in different physiological and pathological conditions and its importance in cell differentiation, tissue formation and development.
Storage: Storage at -20°C.
Formula: C24H20N4O
Appearance: Solid
Purity: 99.9%
Identity: Confirmed by NMR and HPLC.
Targets&IC50: ALK2: 107.9 nM
Relative Density: 1.24 g/cm3

Library Information

Plate Number: AOCL-3
Plate Location: c7
Empty Location: a1-h1; a12-h12
Formulation: 10mM DMSO
Container: 96-well plate
Pathways: Angiogenesis; Autophagy; Tyrosine kinase/adaptors; Stem cells
Targets: ALK; TGF-beta/Smad; Autophagy
Receptors: ALK2; Autophagy; TGF-β receptor
DMSO Max Solubility (mg/mL): 12.5 mg/mL
DMSO Max Solubility (mM): 32.86 mM
Water Max Solubility (mg/mL): 1 mg/mL
Ethanol Max Solubility (mg/mL): 1 mg/mL
Saline Max Solubility (mg/mL): 1.25 mg/mL
Saline Max Solubility (mM): 3.29 mM
ALogP: 4.036
HBA_Count: 4
Rotatable Bond: 4
Inquiry

Copyright © Protheragen. All rights reserves.